Company Overview
BIOMARIN PHARMACEUTICAL INC
BMRNRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
3,221M
2025 FY
Net Income
349M
2025 FY
Shares Outstanding
192M
2025 FY
EPS
1.82USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1048477
Exchange
Nasdaq
Location
US